DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Curosurf (Poractant Alfa) - Shock - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Shock (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Curosurf (Poractant Alfa) where reactions include shock. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Curosurf side effects in female

Reported by a physician from China on 2012-01-04

Patient: female

Reactions: Dyspnoea, Pallor, Oxygen Saturation Decreased, Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Curosurf
    Dosage: daily dose 120 milligrams;unknown
    Indication: Neonatal Respiratory Distress Syndrome Prophylaxis
    Start date: 2011-11-07
    End date: 2011-11-07

Curosurf
    Dosage: daily dose 120 milligrams;unknown
    Indication: Oxygen Saturation Abnormal
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Mezlocillin (Mezlocillin); Etamsilate (Etamsilate); Cefotiam (Cefotiam); Oxygen (Oxygen); Ambroxol (Ambroxol)



Possible Curosurf side effects in male

Reported by a physician from China on 2012-01-04

Patient: male

Reactions: Peripheral Coldness, Dyspnoea, Rales, Erythema, Pallor, Poor Peripheral Circulation, Sepsis, Oxygen Saturation Decreased, Shock, Infantile Apnoeic Attack

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Curosurf

Other drugs received by patient: Etamsilate (Etamsilate); Cefotiam (Cefotiam); Mezlocillin (Mezlocillin); Ambroxol (Ambroxol)



Possible Curosurf side effects in male

Reported by a physician from China on 2012-01-04

Patient: male

Reactions: LOW Birth Weight Baby, Anaemia Neonatal, Neonatal Respiratory Distress Syndrome, Metabolic Acidosis, Neonatal Pneumonia, Disseminated Intravascular Coagulation, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Hypocalcaemia, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Piperacillin W / Sulbactam Sodium (NO Pref. Name)
    Dosage: daily dose 0.18 grams;twice a day
    Indication: Pneumonia
    Start date: 2011-09-19
    End date: 2011-09-23

Curosurf
    Dosage: daily dose 240 milligrams;daily
    Indication: Neonatal Respiratory Distress Syndrome
    Start date: 2011-09-19
    End date: 2011-09-20

Other drugs received by patient: Haemocoagulase (Haemocoagulase); Etamsilate (Etamsilate); Phenobarbital TAB; Cefodizime (Cefodizime)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017